life sciences

Welcome to the 'life-sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'life-sciences'.

Latest blogosphere posts tagged “life-sciences”

• ATG Banks $101M, Veracode Collects $12M, & More Boston-Area Deals News

  
  Xconomy — Authority: 683
  Roundup , deals , startups Rebecca Zacks wrote: It’s only been a few days since I last rounded up the deals news from New England’s tech and life sciences companies, but there are still a few new transactions to report. —Irvine, CA-based Allergan (NYSE: AGN ) revealed in an earnings report that it ...
  2 hours ago

• What’s Your Breakthrough Idea? Let’s Talk About How to Change the World on March 29

  
  Xconomy — Authority: 683
  ideas , events , Xconomy Gregory T. Huang wrote: Whether you’re an entrepreneur, an investor, a researcher, a corporate executive, a journalist, or a patent attorney, you’ve heard it: an idea that will supposedly change the world. In fact, you probably come across someone trying to pitch you an idea ...
  10 hours ago

• Sequenom Gets Rights to Genetic Test for Vision Disorder

  
  Xconomy — Authority: 683
  Licensing Agreement , Genetic Testing , Macular Degeneration Bruce V. Bigelow wrote: San Diego-based Sequenom (NASDAQ: SQNM ) says it has obtained rights to develop and commercialize a diagnostic test from New Haven, CT-based Optherion to predict a patient’s genetic predisposition to late-stage, ...
  12 hours ago

• Licensing deal could bring work to Grand Rapids genetics lab

  
  Detroit Business News — Authority: 805
  Licensing the rights to develop a genetic diagnostic test for an eye disease that can lead to blindness means more work for Sequenom Inc.’s lab in Grand Rapids.The San Diego-based Sequenom today said it has signed a global licensing deal...
  15 hours ago

• Up Next: Outsourcing for Sequencing

  
  Science Progress — Authority: 572
  In a recent discussion on the growth of scientific research in China , a group of experts debated whether the country has the intellectual, financial, and management resources to surpass the United States as the world leader in scientific innovation. As a medical researcher and frequent visitor to China, I believe ...
  17 hours ago

• San Diego’s Halozyme Therapeutics Seeks Biotech Cure for Cellulite

  
  Xconomy — Authority: 683
  Life Sciences , Cosmetic Treatments , Cellulite Denise Gellene wrote: Cellulite is the bane of women everywhere. Caused by the irregular tightening of connective fibers between the muscle and skin, cellulite mars the rump and thighs with uneven dimples and bulges, as if a layer of cottage cheese lies ...
  20 hours ago

• Intrasphere Technologies Launches PharmaCM CTR Express: A Comprehensive Clinical Trial Registration and Results Disclosure System Offered As a Pre-Configured, Quick-to-Deploy Solution

  
  eReleases Press Release Headlines — Authority: 449
  
  20 hours ago

• Infinity’s New CEO, Veteran Dealmaker, Looks Far Ahead to Commercial Future

  
  Xconomy — Authority: 683
  Biotech , people , cancer Luke Timmerman wrote: The story of Infinity Pharmaceuticals can be told through three people. Steve Holtzman got the company started, and raised the money for the company’s proprietary chemistry. Julian Adams brought the focus on cancer drugs. Now it’s up to Adelene Perkins ...
  21 hours ago

• Relocated Biotech Raises $2.3M

  
  Xconomy — Authority: 683
  Life Sciences , Financing , Biomedical Devices Bruce V. Bigelow wrote: NexMed (NASDAQ: NEXM ), a New Jersey life sciences company that moved to San Diego following its acquisition three months ago of Bio-Quant, a San Diego contract research organization (CRO), says today it has raised $2.3 million in ...
  1 day ago

• Is High-Speed Rail The Answer For Warsaw?

  
  | Creo Quality, LLC — Authority: 132
  Have you heard of Warsaw, Indiana? If not, I’m guessing you are likely not in the medical device industry. Warsaw is regarded as the Orthopedics Capital of the world.I came across a post from Ed Morrison titled “The Midwest High-Speed Rail Initiative” and was reminded of a recent article talking about the ...
  1 day ago

• Cell Therapeutics Shares Fall as FDA Says Lymphoma Drug Has “Substantial” Side Effects

  
  Xconomy — Authority: 683
  Biotech , cancer , FDA Luke Timmerman wrote: Seattle-based Cell Therapeutics’ experimental drug for non-Hodgkin’s lymphoma was tested in “substantially fewer” patients than planned in a pivotal clinical trial, and the data that it gathered to support its application shows the treatment has ...
  1 day ago

• Solace Pharma Closes Boston-Area Office After Pain Treatment Fails in Clinical Trial

  
  Xconomy — Authority: 683
  Life Sciences , VC , Biotech Ryan McBride wrote: Solace Pharmaceuticals has quietly shuttered its office in Cambridge, MA, near the team of biologists and venture capitalists who formed the startup in 2006 to develop new treatments for pain, company CEO Eliot Forster confirmed for Xconomy. The firm, ...
  1 day ago

• Optimer Rises on Takeover Buzz and Clinical Trial Results; Still Faces Business Risks

  
  Xconomy — Authority: 683
  Biotech , Antibiotics , Finances Luke Timmerman wrote: One of the buzzwords I keep hearing is that biotech investors want companies that are “de-risked.” This is kind of amusing, because the complex nature of biology makes biotech drug development one of the riskiest investments of all. But this ...
  1 day ago

• Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women

  
  Xconomy — Authority: 683
  Biotech , Weight Loss , Drugs Luke Timmerman wrote: Zafgen arrived on the Boston biotech scene about 18 months ago with blue-chip venture backing, a highly regarded scientist as CEO, and an audacious idea. The Cambridge, MA-based company was developing a powerful new weight loss drug made to work ...
  2 days ago

• Tragara Raises $5M

  
  Xconomy — Authority: 683
  Life Sciences , funding , cancer Bruce V. Bigelow wrote: San Diego-based Tragara Pharmaceuticals , which has focused its current drug development on two compounds for treating tumors, has raised $5 million of a targeted $10 million venture round, according to a recent regulatory filing . The company ...
  2 days ago

• Opinion: One mans dream for life sciences

  
  Detroit Business News — Authority: 805
  File photoRob DeWit, Southwest Michigan Innovation CenterIn a recent phone call with various parties about the upcoming Business Review life sciences forum at Western Michigan University, I stated that one potential topic for the future would be collaboration in the...
  4 days ago

• Allergan Buys Serica Technologies

  
  Xconomy — Authority: 683
  Life Sciences , deals , Biomaterials Ryan McBride wrote: Medford, MA-based biomaterials provider Serica Technologies was acquired late last year by Allergan, the health care products company that makes onabotulinumtoxinA (Botox). Irvine, CA-based Allergan (NYSE: AGN ) revealed the buyout in its earnings ...
  4 days ago

• They’re Not Perfect Cells, But They’re Model Cells

  
  Science Progress — Authority: 572
  In his final column for Science Progress , Rick Weiss responded to critics of stem cell research who argue that injections of stem cells will never serve as treatments for certain chronic diseases. True enough, Weiss wrote, injections of stem cells are unlikely to serve as a treatment for conditions like ...
  4 days ago

• Ironwood Goes Public, Glasshouse and BG Medicine Aim to Do the Same, Vivox Collects $6.8M, & More Boston-Area Deals News

  
  Xconomy — Authority: 683
  Roundup , deals , IPOs Rebecca Zacks wrote: For the first time in as long as I can remember, IPOs dominated the New England tech and life sciences deals news this week. —Glasshouse Technologies, an IT consulting firm in Framingham, MA, indicated in an SEC filing that it’s planning an initial public ...
  5 days ago

• Electronically Dispatching Work Procedures

  
  Emerson Process Experts — Authority: 121
  I saw a tweet yesterday , which pointed to a great BioProcess International article, Biopharmaceutical Information Infrastructure 2.0 (Part 1 of 2) . I sent the link to Emersons Jonathan Lustri , who manages the Syncade smart operations management brand for his thoughts. I thought they were great and needed no ...
  5 days ago

Comments about life-sciences